Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BDSX · against 228 other Healthcare companies of similar size
Ranked #37 of 229 · scores higher than 83% of peers
Bars: peers in each 10-point band of the growth score20 peers with a growth score of 80–89, including BDSX · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | BDSX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 241 reported | 34.5% | 3.0% | 86% | 33% | |
| Earnings per share growthHigher is better · 95 reported | Not reported | 5.5% | — | — | 33% |
| 3-year revenue growthHigher is better · 222 reported | 35.2% | 3.8% | 90% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 1 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 1 | 433M USD | 99 | 81 | |
| 5 | 5.7B TWD (≈$177M) | 98 | 65 | |
| 33 | 2.4B CNY (≈$331M) | 85 | 51 | |
| 33 | 393M USD | 85 | 50 | |
| 33 | 5.1B MXN (≈$274M) | 85 | 48 | |
| 33 | 303M USD | 85 | 27 | |
| 37 | 222M USD | 84 | 31 | |
| 37 | 399M USD | 84 | 32 | |
| 37 | 126M USD | 84 | 32 | |
| 40 | 267M USD | 83 | 75 | |
| 41 | 5.3B TWD (≈$165M) | 82 | 69 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score